LSX, formerly Biotech and Money, is an influential community of senior life science decision makers. We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. We achieve this through a programme of high-level conferences and networking events, via content that showcases and shares the expertise of investors, senior leaders and industry stakeholders, as well as through bespoke initiatives.
Key learnings: Vesalius BioCapital III Partners invested €4 million in Finl...Read More
Pre-approval access is evolving at a rapid pace. Mark Corbett (pictured), E...Read More
The 2018 C-Suite Challenges in Life Sciences Survey from Biotech & Money/LS...Read More